Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-18

Clinical Trial Update: A First-in-Man Clinical Trial to Evaluate the Safety and Feasibility of ICS-Elpis in Patients With Iliac Artery Stenosis or Occlusion Lesions [NA]

View source ↗

Summary

A first-in-man clinical trial to evaluate the safety and feasibility of ICS-Elpis for iliac artery stenosis or occlusion; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ICS-Elpis

Snippet

Sponsor: Biotyx Medical (Shenzhen) Co., Ltd. | Conditions: Iliac Artery Stenosis, Iliac Artery Occlusion | NA | Status: NOT_YET_RECRUITING